Hints and tips:
Related Special Reports
...EU regulators have delayed a decision to approve Novavax’s variant-tailored Covid-19 vaccine, in a setback for the US-listed biotech which is battling a slump in demand for coronavirus jabs....
...And it plans to acquire oncology-focused biotech Seagen for $43bn, which it expects to contribute more than $10bn in 2030 sales....
World’s biggest gene sequencing company rejects EU’s fast- track application
...Shah called for Suresh Katta and Venkat Peri, both chief executives of other biotechs, to be nominated for the independent board roles....
...It says it needs improved access to capital, but it claims to be one of the largest biotech fundraisers in recent years....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...On a busy day at work in 2016, Matthew Panuwat took a break from his biotech executive job to make a stock trade on his computer....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
...A group of Wall Street traders maliciously drove down the share price of a Maryland biotech with a promising new brain cancer vaccine, in pursuit of the marginal profits to be made by buying the stock cheaply...
...The German biotech group said on Monday that it had been informed by Pfizer that the majority of the write-offs related to raw materials purchased during the pandemic, mainly the lipids that deliver the...
...EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge of the...
...Illumina has appointed Jacob Thaysen as its new chief executive, as the biotech group seeks to rebuild its leadership team following a bruising battle with activist investor Carl Icahn....
...Need to know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight...
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...in private markets (FT) Telegraph takeover by RedBird IMI faces regulatory probe (FT) Gucci owner Kering issues rare luxury sector profit warning (FT) AstraZeneca strikes $2.4bn deal for radiotherapy biotech...
...The move shook the sector, where large drugmakers rely on buying smaller biotechs to replenish their stocks of innovative medicines as drugs go off patent....
...Illumina, the world’s biggest gene sequencing company, announced plans to buy cancer detection start-up Grail for $8bn while the biotech boom was in full swing....
...The biotech entrepreneur also accused Fink of “telling Exxon and Chevron they can’t drill here”....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...The oncology-focused biotech agreed a $43bn deal to be acquired by Pfizer....
...He said most partners were moving to protect long-term relationships with the biotech industry in the knowledge that the next pandemic could be “right around the corner”....
...Monday’s acquisition by Novartis of Seattle-based biotech firm Chinook Therapeutics for up to $3.5bn is a case in point....
Gene sequencing company heads for pivotal vote in battle with activist investor Carl Icahn
...Despite a significant drop in biotech stocks over the past year, large pharmaceutical companies have shown little interest in picking up assets cheaply....
...He said the acquisition may signal a shift in activity in the pharmaceutical sector towards more aggressive deployment of cash to scoop up biotech companies....
International Edition